Grade Summary: Maryland
Tobacco Prevention Control and Spending
- FY2012 State Funding for Tobacco Control Programs: $4,316,255
- FY2012 Federal Funding for State Tobacco Control Programs: $1,687,600*
- FY2012 Total Funding for State Tobacco Control Programs: $6,003,855
- CDC Best Practices State Spending Recommendation: $63,300,000
- Percentage of CDC Recommended Level: 9.5%
*Includes regular funding from the Centers for Disease Control and Prevention as well as tobacco-related grants to states and communities from federal stimulus and health care reform funds.
Smokefree Air
Overview of State Smoking Restrictions
- Government Workplaces: Prohibited
- Private Workplaces: Prohibited
- Schools: Prohibited
- Childcare Facilities: Prohibited
- Restaurants: Prohibited
- Bars: Prohibited
- Casinos/Gaming Establishments: Prohibited
- Retail Stores: Prohibited
- Recreational/Cultural Facilities: Prohibited
- Penalties: Yes
- Enforcement: Yes
- Preemption: No
Citation: MD. CODE ANN., HEALTH-GEN. §§ 24-501 to 24-511 (2008) & MD. CODE ANN., LAB. & EMPLOY. §§ 5-101 & 5-608 (2008).
Cigarette Tax
- Tax rate per pack of 20: $2
Cessation
Overview of State Cessation Coverage
State Medicaid Program:
- Medications: Coverage for all 7 recommended cessation medications* varies by health plan
- Counseling: Coverage for group and individual counseling required for pregnant women; coverage varies for other enrollees
- Barriers to Coverage: Barriers to coverage vary by health plan**
State Employee Health Plan(s):
- Medications: Covers Bupropion (Zyban) and Varenicline (Chantix)
- Counseling: Covers individual and phone counseling
- Barriers to Coverage: No barriers
State Quitline:
- Investment Per Smoker: $1.20; CDC recommends an investment of $10.53/smoker
Other Cessation Provisions:
- Private Insurance Mandate: Yes
Citation: See State Tobacco Cessation Coverage page for specific sources.
*The 7 recommended cessation medications are: NRT Gum, NRT Patch, NRT Nasal Spray, NRT Inhaler, NRT Lozenge, Varenicline (Chantix) and Bupropion (Zyban).
**Barriers could include: Limits on duration, annual limits on quit attempts, requiring prior authorization, requiring co-payments, requiring using one or more cessation treatments before using others and/or requiring the use of counseling to receive medications.


